VLDLR Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of VLDLR monoclonal antibodies for investigating the very low-density lipoprotein receptor (VLDLR) in various biological processes. VLDLR monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VLDLR is crucial for lipid metabolism and plays a significant role in neuronal development and function. VLDLR actively participates in the uptake of lipoproteins and maintains lipid homeostasis in the body. Research has shown that VLDLR dysregulation is associated with various metabolic disorders and neurological conditions. Understanding VLDLR function and regulation provides valuable insights into potential therapeutic approaches for related diseases. VLDLR research continues to reveal new pathways and mechanisms in cellular metabolism and development. VLDLR monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific understanding of metabolic and neurological processes, contributing to the development of new therapeutic strategies.